A 3-year-old child presents with recurrent episodes of hypoketotic hypoglycemia, developmental delay, and hepatomegaly. Plasma lactate is markedly elevated (8 mmol/L, normal <2). Urine organic acids show elevated dicarboxylic acids. Which investigation is most appropriate to confirm a defect in the TCA cycle?

## Clinical Presentation Analysis This child presents with classic features of a TCA cycle disorder: - Hypoketotic hypoglycemia (impaired energy production) - Developmental delay (CNS involvement from mitochondrial dysfunction) - Hepatomegaly (hepatic energy crisis) - Markedly elevated lactate (anaerobic metabolism due to impaired oxidative capacity) - Dicarboxylic aciduria (incomplete oxidation of fatty acids) ## Investigation Hierarchy for TCA Cycle Disorders | Investigation | Role | Sensitivity | Specificity | |---|---|---|---| | **Enzyme assay in fibroblasts** | **Definitive diagnosis** | **High** | **High** | | Plasma lactate/pyruvate ratio | Screening only | Moderate | Low (non-specific) | | MR spectroscopy | Tissue assessment | Moderate | Low (shows consequence, not cause) | | Urine amino acids | Non-contributory | Low | Very low | ## Key Point: **Enzyme assay of fumarase (or other TCA cycle enzymes) in cultured fibroblasts is the gold standard confirmatory test.** This directly measures the defective enzyme activity and provides genetic/biochemical diagnosis. ## Why This Approach? 1. **Fibroblasts are accessible** — skin biopsy is non-invasive; cultured cells allow enzyme measurement 2. **TCA cycle enzymes are present** — fibroblasts express all TCA cycle enzymes at measurable levels 3. **Deficiency is demonstrable** — reduced enzyme activity correlates with clinical severity 4. **Allows genetic counseling** — specific enzyme defect guides molecular testing ## High-Yield: **Fumarase deficiency** is the most common TCA cycle disorder presenting in infancy/early childhood with lactic acidosis and neurological symptoms. Enzyme assay confirms it; genetic sequencing (FH gene) follows. ## Clinical Pearl: Plasma lactate/pyruvate ratio alone cannot distinguish TCA cycle defects from other causes of lactic acidosis (mitochondrial respiratory chain disorders, pyruvate dehydrogenase deficiency). Tissue enzyme measurement is required for specificity.